BHCM
PROK icon

Brevan Howard Capital Management’s ProKidney PROK Stock Holding History

Brevan Howard Capital Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Buy
+64,153
New +$136K ﹤0.01% 1995

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Brevan Howard Capital Management's PROK Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in ProKidney (PROK) in Q1 2026: 64,153 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #1995 among its holdings.

71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Brevan Howard Capital Management held 64,153 shares of ProKidney worth $115K as of Q1 2026.
  • ProKidney was a new Brevan Howard Capital Management position in Q1 2026.
  • ProKidney made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1995 holding.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.